Last Posted: Sep 01, 2019
- Clostridioides difficile : diagnosis and treatments.
Guery Benoit et al. BMJ (Clinical research ed.) 2019 Aug l4609 - Host immune markers distinguish C. difficile infection from asymptomatic carriage and non-C. difficile diarrhea
Kelly CP, et al. Clin Infect Dis, Apr 26, 2019. - Whole genome sequencing of toxigenic C. difficile in asymptomatic carriers: insights into possible role in transmission.
Halstead Fenella D et al. The Journal of hospital infection 2018 Oct - Local Coverage Determination (LCD): Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) (L37709)
The U.S. Centers for Medicare & Medicaid Services - New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability.
Kirk Joseph A et al. Science translational medicine 2017 Sep (406) - Donor microbes persist two years after fecal transplant to treat C. difficile infection
Science Mag, June 13, 2017 - Laboratory Testing of Donors and Stool for Fecal Microbiota Transplantation for Recurrent C. difficile Infection.
Woodworth Michael H et al. Journal of clinical microbiology 2017 Jan - Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
Longtin Yves et al. JAMA internal medicine 2016 Apr - Breakthroughs in the treatment and prevention of Clostridium difficile infection
LK. Kociolek et al, Nature Reviews Gastroenterology, February 2016 - Diagnosis of Clostridium difficile Infection Treat the Patient, Not the Test
ER Dubberke et al. JAMA Internal Medicine, September 8, 2015
.png)
No hay comentarios:
Publicar un comentario